Latest Breaking News On - Other rare lysosomal diseases - Page 1 : comparemela.com

Shares of Avrobio were up nearly 20% in premarket trading after the company posted positive clinical data from its gene therapy trials in three different rare lysomal diseases, Fabry, Gaucher type 1 and cystinosis.

United kingdomGeoff mackayChief executive officer geoff mackayAvrobio gene therapy shows early promise in fabryOther rare lysosomal diseasesஒன்றுபட்டது கிஂக்டம்ஜியோஃப் மகேதலைமை நிர்வாகி அதிகாரி ஜியோஃப் மகே